IM
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ·Healthcare·Biotechnology
$3.15
-0.63%
Mkt Cap $154.79M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+281.0%
Consensus $12.00 vs current $3.15